At the news
? BEARISHIMPACT 8/10 8-K filed Apr 15, 2026 at 16:32 ET
Alaunos Therapeutics (TCRT) received a delisting notice from Nasdaq due to failing to maintain the $2.5 million minimum stockholders' equity requirement, reporting $2.15 million as of December 31, 2025. The company has 45 days to submit a compliance plan and may request a hearing if needed.
- Received Nasdaq delisting notice on April 9, 2026, for failing to meet $2.5 million stockholders' equity requirement
- Reported stockholders' equity of $2,153,000 as of December 31, 2025
- Does not meet alternative listing standards (market value or net income)
- Has 45 days (until May 26, 2026) to submit a compliance plan
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access